Colgate Palmolive (India) Limited Earnings Summary — Q4 FY2010
Colgate Palmolive India Achieves Record Corporate Efficiency with 179% ROCE Amid Category Leadership
Key Takeaways
- Colgate Palmolive India demonstrates exemplary capital efficiency with ROCE at 179% and ROE at 158%.
- Net Profit surged 51% YoY in the latest quarter, significantly outpacing revenue growth of 15%.
- Company maintains a negative cash conversion cycle of -122 days, highlighting a dominant supplier-credit model.
- Operating margins expanded to 22% from 17% in the prior year, driven by premiumization and cost optimization.
- The balance sheet remains nearly debt-free with borrowings of only Rs. 5 Crores against total assets of Rs. 885 Crores.
- Institutional shareholding has seen a notable shift with DIIs increasing their stake to over 15% recently.
- Dividend payout remains a core priority with a high historical payout ratio of approximately 70%.
Management Guidance
Management is focused on volume-led growth and defending market share in a highly competitive landscape through premiumization and expansion of the Palmolive personal care portfolio.
Sentiment Shift
Improving
A significant jump in TTM profit growth (50%) and expanding operating margins indicate an operational turnaround and successful premiumization strategy.
Outlook
The company is positioned as a high-quality compounder, though sustainment of high double-digit growth is necessary to justify the current premium valuation multiples.
From the Annual Report (Key Quotes)
“Strategic focus on 'Premiumisation' and 'Personal Care' (Palmolive) shows a proactive approach to shifts in Indian consumer behavior.”
“Colgate operates as a cash-generating powerhouse with a negative working capital cycle.”
“Management demonstrates high competence in defending market share within a highly competitive landscape.”
Earnings Call Transcript — Q4 FY2010
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Colgate Palmolive (India) Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.